Clinical Trials Logo

Wound Heal clinical trials

View clinical trials related to Wound Heal.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04960553 Terminated - Wound Heal Clinical Trials

A PMCF Investigation on Exuding Chronic Wounds Using Exufiber® as Primary Dressing, and Mepilex® Border Flex/Comfort

ExuFlex01
Start date: December 7, 2021
Phase: N/A
Study type: Interventional

The overall objective of this post market clinical follow-up (PMCF) investigation is to follow the progress of exuding chronic wounds to healing, or up to 12 weeks, whichever occurs first, consecutively using Exufiber® as primary dressing, and Mepilex® Border Flex (Mepilex Border Comfort) as primary dressing.

NCT ID: NCT04829331 Terminated - Wound Heal Clinical Trials

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

Start date: April 9, 2021
Phase: N/A
Study type: Interventional

Understand association between use of Restrata (Acera Surgical Inc., St. Louis, MO) in forearm flap reconstruction with donor site healing and function

NCT ID: NCT04123093 Terminated - Diabetic Foot Ulcer Clinical Trials

Safety and Efficacy of the Noxsano Wound Care Bandage

Start date: August 9, 2019
Phase: N/A
Study type: Interventional

This study is a prospective, interventional, non-randomized study designed to assess the safety and efficacy of the Noxsano Bandage (study device) in healthy subjects and wound care subjects with a diabetic lower extremity ulceration and/or arterial insufficiency lower extremity ulceration.

NCT ID: NCT04026334 Terminated - Wounds and Injuries Clinical Trials

Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue

Start date: July 25, 2019
Phase: N/A
Study type: Interventional

The study goal is to evaluate the ability of the V.A.C. ULTA™ Negative Pressure Wound Therapy System and V.A.C. VERAFLO CLEANSE CHOICE ™ (VFCC) dressing system with saline as an irrigant in increasing viable tissue in full thickness wounds (such as chronic, acute, traumatic, sub-acute, and dehisced wounds and/or ulcers) with difficult to manage bioburden and slough.

NCT ID: NCT03579160 Terminated - Wound Heal Clinical Trials

Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes

FTSG
Start date: January 2, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The use of topical beta-blockers, such as 0.25% timolol, in promoting wound healing is currently emerging in the academic literature. The investigators will enroll 82 patients who have their skin cancer surgically removed resulting in the need of a full-thickness skin graft. The objective of this randomized safety study is to determine the safety and efficacy of 0.25% timolol in promoting wound healing in full-thickness skin grafts compared to standard of care.

NCT ID: NCT03412929 Terminated - Wound Heal Clinical Trials

A Clinical Evaluation of a Honey Impregnated Dressing at Removing Necrotic Tissue From Chronic Wounds

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a honey-impregnated wound dressing at removing necrotic tissue in subjects with chronic foot or ankle wounds.